View clinical trials related to AHUS.
Filter by:Primary objective - To determine the clinical prognosis by identifying the disease course and severity by treatment with or without eculizumab in patients with aHUS in Korea. Secondary objectives - To determine the clinical prognosis of the disease in all patients with aHUS in Korea. - To determine the clinical prognosis of the disease in patients diagnosed with aHUS prior to the initiation of eculizumab reimbursement system in Korea. - To determine the treatment responses by treatment options in patients with aHUS in Korea. - To identify risk factors that affect mortality in all patients with aHUS in Korea. - To investigate the recurrence and clinical prognosis in patients with aHUS in Korea when eculizumab is discontinued
It is a multicenter observational non-comparative study of the efficacy and safety of long-term pathogenetic Elizaria® therapy in patients with atypical Hemolytic Uremic Syndrome
This is a Phase II, single arm, open-label study to determine if treatment with eculizumab prolongs pregnancy compared to historical controls in women with preeclampsia between 23-30 weeks gestation.